These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 26837867

  • 1. Germline RET mutation carriers in Japanese patients with apparently sporadic medullary thyroid carcinoma: A single institution experience.
    Kihara M, Miyauchi A, Yoshioka K, Oda H, Nakayama A, Sasai H, Yabuta T, Masuoka H, Higashiyama T, Fukushima M, Ito Y, Kobayashi K, Miya A.
    Auris Nasus Larynx; 2016 Oct; 43(5):551-5. PubMed ID: 26837867
    [Abstract] [Full Text] [Related]

  • 2. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.
    Elisei R, Bottici V, Cappagli V, Ramone T, Tacito A, Ciampi R, Romei C.
    Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251
    [Abstract] [Full Text] [Related]

  • 3. Screening of RET gene mutations in Chinese patients with medullary thyroid carcinoma and their relatives.
    Wang J, Zhang B, Liu W, Zhang Y, Di X, Yang Y, Yan D.
    Fam Cancer; 2016 Jan; 15(1):99-104. PubMed ID: 26254625
    [Abstract] [Full Text] [Related]

  • 4. Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.
    Eng C, Mulligan LM, Smith DP, Healey CS, Frilling A, Raue F, Neumann HP, Ponder MA, Ponder BA.
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):123-7. PubMed ID: 7641404
    [Abstract] [Full Text] [Related]

  • 5. Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.
    Aydoğan Bİ, Yüksel B, Tuna MM, Navdar Başaran M, Akkurt Kocaeli A, Ertörer ME, Aydın K, Güldiken S, Şimşek Y, Cihan Karaca Z, Yılmaz M, Aktürk M, Anaforoğlu İ, Kebapçı N, Duran C, Taşlıpınar A, Kulaksızoğlu M, Gürsoy A, Dağdelen S, Erdoğan MF.
    J Clin Res Pediatr Endocrinol; 2016 Mar 05; 8(1):13-20. PubMed ID: 26758973
    [Abstract] [Full Text] [Related]

  • 6. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
    Elisei R, Romei C, Cosci B, Agate L, Bottici V, Molinaro E, Sculli M, Miccoli P, Basolo F, Grasso L, Pacini F, Pinchera A.
    J Clin Endocrinol Metab; 2007 Dec 05; 92(12):4725-9. PubMed ID: 17895320
    [Abstract] [Full Text] [Related]

  • 7. Unilateral surgery supported by germline RET oncogene mutation analysis in patients with sporadic medullary thyroid carcinoma.
    Miyauchi A, Matsuzuka F, Hirai K, Yokozawa T, Kobayashi K, Kuma S, Kuma K, Futami H, Yamaguchi K.
    World J Surg; 2000 Nov 05; 24(11):1367-72. PubMed ID: 11038208
    [Abstract] [Full Text] [Related]

  • 8. M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds.
    Martins-Costa MC, Cunha LL, Lindsey SC, Camacho CP, Dotto RP, Furuzawa GK, Sousa MS, Kasamatsu TS, Kunii IS, Martins MM, Machado AL, Martins JR, Dias-da-Silva MR, Maciel RM.
    Endocr Relat Cancer; 2016 Dec 05; 23(12):909-920. PubMed ID: 27807060
    [Abstract] [Full Text] [Related]

  • 9. Current understanding and management of medullary thyroid cancer.
    Roy M, Chen H, Sippel RS.
    Oncologist; 2013 Dec 05; 18(10):1093-100. PubMed ID: 24037980
    [Abstract] [Full Text] [Related]

  • 10. Lymph node metastasis in hereditary medullary thyroid cancer is independent of the underlying RET germline mutation.
    Machens A, Lorenz K, Weber F, Dralle H.
    Eur J Surg Oncol; 2021 Apr 05; 47(4):920-923. PubMed ID: 32962888
    [Abstract] [Full Text] [Related]

  • 11. Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
    Romei C, Tacito A, Molinaro E, Agate L, Bottici V, Viola D, Matrone A, Biagini A, Casella F, Ciampi R, Materazzi G, Miccoli P, Torregrossa L, Ugolini C, Basolo F, Vitti P, Elisei R.
    Clin Endocrinol (Oxf); 2015 Jun 05; 82(6):892-9. PubMed ID: 25440022
    [Abstract] [Full Text] [Related]

  • 12. Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection.
    Huang Q, Hu A, Zhang M.
    BMC Endocr Disord; 2020 May 14; 20(1):64. PubMed ID: 32408902
    [Abstract] [Full Text] [Related]

  • 13. Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.
    Barletta JA, Nosé V, Sadow PM.
    Endocr Pathol; 2021 Mar 14; 32(1):35-43. PubMed ID: 33492588
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma.
    Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Miyauchi A, Nakamura Y.
    J Hum Genet; 1998 Mar 14; 43(2):101-6. PubMed ID: 9621513
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oncological features of sporadic vs. hereditary pediatric medullary thyroid cancer.
    Machens A, Lorenz K, Weber F, Dralle H.
    Endocrine; 2024 Sep 14; 85(3):1091-1095. PubMed ID: 39003661
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
    Bugalho MJ, Domingues R, Santos JR, Catarino AL, Sobrinho L.
    Surgery; 2007 Jan 14; 141(1):90-5. PubMed ID: 17188172
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.